Capstone Investment Advisors’s Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock ARCK Stock Holding History

Capstone Investment Advisors’s Portfolio ARCK Stock Details ARCK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-100,000	Closed	-$1.01M	–	1706
2022 Q3	$1.01M	Hold	100,000	–	–	0.01%	1006
2022 Q2	$1M	Hold	100,000	–	–	﹤0.01%	1001
2022 Q1	$1M	Buy	+100,000	New	+$1M	﹤0.01%	1309

Other funds holding ARCK

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Capstone Investment Advisors's ARCK Position: Q4 2022 in Review

Capstone Investment Advisors sold out of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) in Q4 2022, closing a stake of 100,000 shares — an estimated $1.01M sold.

Capstone Investment Advisors first reported a position in ARCK in Q1 2022 and held it in 3 quarters. The position peaked at $1.01M in Q3 2022. 2 funds tracked by Wall St. Rank hold ARCK as of Q4 2022.

Capstone Investment Advisors reported no remaining Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Capstone Investment Advisors sold 100,000 Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock shares in Q4 2022, an estimated $1.01M.
Capstone Investment Advisors first reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in Q1 2022 and held it in 3 quarters.
Capstone Investment Advisors's Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position peaked at $1.01M in Q3 2022.
2 funds tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock as of Q4 2022.

Based on Capstone Investment Advisors's 13F filing for Q4 2022, filed 10 Feb 2023.